家族の絆をAIで支える『母の日チャリティーAIコンテスト』始動 #東京都 #渋谷区 #シングルマザー #WIZAI #JACC
生成AIを活用した『母の日チャリティーAIコンテスト』が開催され、シングルマザー家庭への温かい支援を目指します。
The joint EAPC/ESC and ACC Clinical Consensus Statement provides an in-depth update on the current state of knowledge on abnormal cardiovascular findings in Masters athletes.
Read the journal scan for more 👉 https://bit.ly/4vnexZx #SportsCardio #JACC #CardioSky
感謝の気持ちを形にする母の日チャリティーAIコンテストのご紹介 #母の日 #JACC #大阪焼肉・ホルモン_ふたご
母の日に向けた特別企画、チャリティーAIコンテストが開催!シングルマザー家庭への支援につながる温かい活動をご紹介します。
AI-Powered Charity Contest Offers Single Mothers a Chance for Family Dining #Japan #Tokyo #FTG_Company #Single_Mothers #JACC
🆕 #JACC Spotlight Issue highlights key guideline recommendations for acute #PulmonaryEmbolism through a patient-centered journey – from risk factors to long-term management, while also identifying areas for future clarification and updates.
Read more: https://bit.ly/4cAZoME #CardioSky
Masters Athletes With Abnormal Cardiovascular Findings
A Clinical Consensus Statement of EAPC and ACC
Mild aortic dilatation 40~45 mm seen in 20% Masters runner/rowers & up to 41% former football/rugby players
Any elevated risks for aortic events?🧐
#AortaEd
#JACC 2026
www.jacc.org/doi/10.1016/...
New EAPC/ESC + ACC Statement updates abnormal CV findings in Masters athletes. Expert guidance on AF, bradyarrhythmias, ventricular arrhythmias, CAD, aortic dilatation, myocardial fibrosis, and exercise-induced arrhythmogenic cardiomyopathy. https://bit.ly/3PSoFJw #JACC #SportsCardio #CardioSky
Re-Defining Primary Aldosteronism
authors.elsevier.com/a/1mqFw2d9GI...
@jaccjournals.bsky.social #JACC
In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ACC26, such as STEMI-DTU, ORBITA-CTO, & more!
📽️: youtu.be/xvLFmv2-Et0?...
#JACC #CardioSky @accintouch.bsky.social
#ACC26 DKCRUSH VIII: When using the two-stent DK crush technique for #PCI to treat complex coronary artery bifurcation lesions, IVUS-guided PCI was associated w/ a greater reduction in target vessel failure compared to angiography-guided PCI.
More: 🔗 https://bit.ly/47w3WRR #CardioSky #JACC
#ACC26 CORALreef AddOn: The novel PCSK9 oral inhibitor enlicitide effectively lowered LDL-C in adults already being treated with statins, demonstrating a potential role as an add-on option for patients not meeting LDL-C goals.
Learn more: https://bit.ly/4uW7VRL #JACC #CardioSky
FUND-HF pilot shows feasible early post-discharge financial support in low-income HF patients, improving medication adherence. Findings inform larger trials to assess durability and effects on HRQOL and outcomes. https://bit.ly/4sC2NR7
#JACC #SDOH #QoL #ACC26 #CardioSky
Oral #enlicitide lowered LDL-C, #ApoB, & non-HDL-C more than oral non-statin comparators at day 56 in statin-treated adults with a history of a major #ASCVD event or at increased risk for a first event. https://bit.ly/47Ao7hw
#ACC26 #JACC #PCSK9i #CardioSky
In this RCT of complex bifurcation #PCI using DK crush technique, 1-year benefits of #IVUS-guided PCI were driven by achieving IVUS optimization targets, not IVUS use alone. https://bit.ly/4s1UWek
#JACC #ACC26 #CardioSky
Electronic clinician notification alerts were shown to be effective in improving the timely evaluation & treatment of pts w/ severe #vhdAS or #vhdMR, according to the ALERT trial presented during a Featured Clinical Research session at #ACC26.
More: https://bit.ly/3NTwMVA #JACC #CardioSky
Cluster randomized trial: Automated ECN alerts improved timely guideline-directed evaluation & valve intervention for sig. AS & MR, supporting scalable EHR-based decision support to reduce undertreatment & improve access to valve care https://bit.ly/4ccYEND
#JACC #ACC26 #vhdAS #vhdMR #CardioSky
In patients with symptomatic single-vessel coronary chronic total occlusion (CTO), #PCI for CTO improved angina beyond placebo, according to findings from the ORBITA-CTO trial presented at #ACC26 and simultaneously published in #JACC.
Learn more: https://bit.ly/4uSdZKR #CardioSky
In patients with symptomatic single-vessel chronic total occlusion, percutaneous coronary intervention for coronary chronic total occlusion (CTO PCI) improves angina beyond placebo.
Get the details in #JACC: https://bit.ly/4tfFPza #ACC26 #PCI #CTO #CardioSky
Late-breaking KARDINAL trial explores efficacy of tonlamarsen in patients with uncontrolled hypertension. Read more in #JACC: bit.ly/4uT83l3
#ACC26 #Hypertension #CardioSky
Combination of a TV-mAFP plus delayed #PCI did not reduce infarct size in patients with anterior #STEMI without cardiogenic shock compared with PCI alone, according to an #ACC26 #JACC LBCT.
Get the details: https://bit.ly/4bEo9aD #CardioSky
New 2026 ACC scientific statement reviews gene editing therapy in #CVD, covering the science, early targets (monogenic diseases), and key ethical and cost challenges. Clinicians play a critical role in guiding safe, equitable use. https://bit.ly/4rYSW6W
#JACC #CRISPR #cvGenetics #CardioSky
Outpatient management of isolated left-to-right shunt lesions in pediatric #CHD is the focus of a new 2026 ACC Concise Clinical Guidance report in #JACC, offering a decision support framework in the current absence of evidence-based clinical guidelines. https://bit.ly/4lRUFcL #cvPed #CardioSky
New multisociety consensus outlines operator & institutional requirements for tricuspid interventions & guidance for implementing & maintaining a transcatheter tricuspid valve intervention program in a rapidly evolving field.
Get the details in #JACC: https://bit.ly/4rUYP4T #vhdTR #TTVI #CardioSky
After the Inflation Reduction Act's 2024 provisions took effect, cost-related medication non-adherence fell among Medicare beneficiaries newly eligible for low-income subsidies at elevated CV risk. https://bit.ly/4bwJmDj
#ACC26 #JACC #CardioSky @rkwadhera.bsky.social
Featured on the @todayshow.com: @nbcnews.com medical reporter Dr. Akshay Syal discusses @accintouch.bsky.social and @americanheart.bsky.social's new guideline for managing #cvLipids and #Cholesterol.
📺Watch the video: on.today.com/4lFVuVY #JACC
The latest commentary by Omar Hahad et al., now published in #ScienceDirect, responds to recent findings by Xue et al. in #JACC and highlights a critical shift in how we understand hypertension-related mortality. 🫀🏥
🔗 Full editorial comment: www.sciencedirect.com/science/arti...
🆕 #JACC Leadership Page outlines the legacy of collaboration between @sts.org and ACC, and explores the ways the two societies are upholding standards while expanding horizons with #ACCPresident Dr. @chriskramermd.bsky.social & STS President Dr. Vinay Badhwar.
🔗 https://bit.ly/3PLvH2u #ACCLeadership
The 2026 ACC/AHA Multisociety #Dyslipidemia Guideline-at-a-Glance offers a visual summary of key updates in CV risk assessment, lipid treatment goals, & #ASCVD risk reduction.
A quick reference for clinicians: https://bit.ly/4rGIMHY
#JACC #ClinicalGuidelines #cvLipids #CardioSky
🆕 ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive “one-stop shop” for addressing the evaluation, management & monitoring of individuals w/ dyslipidemias.
Read the full guideline in #JACC: https://bit.ly/4cLB0J0 #cvLipids #ClinicalGuidelines #CardioSky #MedSky
ACC/AHA & 9 other leading medical associations released an updated clinical guideline for managing #dyslipidemia. About 1 in 4 US adults has high LDL-C, raising risk of heart attack & stroke.
Get the details in #JACC: https://bit.ly/4cLB0J0
#ClinicalGuidelines #cvLipids #ASCVD #CardioSky